• Je něco špatně v tomto záznamu ?

WBP1L regulates hematopoietic stem cell function and T cell development

I. Krayem, S. Grusanovic, I. Duric, N. Pavliuchenko, P. Danek, S. Borna, J. Sekeresova Kralova, T. Skopcova, J. Pokorna, M. Alberich-Jorda, T. Brdicka

. 2024 ; 15 (-) : 1421512. [pub] 20241101

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003550

WW domain binding protein 1-like (WBP1L), also known as outcome predictor of acute leukemia 1 (OPAL1), is a transmembrane adaptor protein, expression of which was shown to correlate with ETV6-RUNX1 translocation and favorable prognosis in childhood leukemia. It has a broad expression pattern in hematopoietic and non-hematopoietic cells. Our previous work described WBP1L as a regulator of CXCR4 signaling and hematopoiesis. Here, we show that hematopoiesis in the mice with Wbp1l germline deletion is dysregulated, already at the level of hematopoietic stem cells and early progenitors. We further demonstrate that thymi of WBP1L-deficient mice are significantly enlarged and contain increased numbers of thymocytes of all subsets. This can potentially be explained by increased generation of multipotent progenitors 4 (MPP4) in the bone marrow, from which the thymus-seeding progenitors are derived. We also observed increases in multiple cell types in the blood. In addition, we show that WBP1L regulates hematopoietic stem cell functionality and leukocyte progenitor proliferation and gene expression during hematopoietic stem and progenitor cell transplantation, which contribute to more efficient engraftment of WBP1L-deficient cells. WBP1L thus emerges as a regulator of hematopoietic stem and progenitor cell function, which controls leukocyte numbers at the steady state and after bone marrow transplantation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003550
003      
CZ-PrNML
005      
20250206104415.0
007      
ta
008      
250121e20241101sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2024.1421512 $2 doi
035    __
$a (PubMed)39555063
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Krayem, Imtissal $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
245    10
$a WBP1L regulates hematopoietic stem cell function and T cell development / $c I. Krayem, S. Grusanovic, I. Duric, N. Pavliuchenko, P. Danek, S. Borna, J. Sekeresova Kralova, T. Skopcova, J. Pokorna, M. Alberich-Jorda, T. Brdicka
520    9_
$a WW domain binding protein 1-like (WBP1L), also known as outcome predictor of acute leukemia 1 (OPAL1), is a transmembrane adaptor protein, expression of which was shown to correlate with ETV6-RUNX1 translocation and favorable prognosis in childhood leukemia. It has a broad expression pattern in hematopoietic and non-hematopoietic cells. Our previous work described WBP1L as a regulator of CXCR4 signaling and hematopoiesis. Here, we show that hematopoiesis in the mice with Wbp1l germline deletion is dysregulated, already at the level of hematopoietic stem cells and early progenitors. We further demonstrate that thymi of WBP1L-deficient mice are significantly enlarged and contain increased numbers of thymocytes of all subsets. This can potentially be explained by increased generation of multipotent progenitors 4 (MPP4) in the bone marrow, from which the thymus-seeding progenitors are derived. We also observed increases in multiple cell types in the blood. In addition, we show that WBP1L regulates hematopoietic stem cell functionality and leukocyte progenitor proliferation and gene expression during hematopoietic stem and progenitor cell transplantation, which contribute to more efficient engraftment of WBP1L-deficient cells. WBP1L thus emerges as a regulator of hematopoietic stem and progenitor cell function, which controls leukocyte numbers at the steady state and after bone marrow transplantation.
650    _2
$a zvířata $7 D000818
650    12
$a hematopoetické kmenové buňky $x metabolismus $x cytologie $7 D006412
650    _2
$a myši $7 D051379
650    12
$a myši knockoutované $7 D018345
650    12
$a hematopoéza $x genetika $7 D006410
650    _2
$a T-lymfocyty $x imunologie $x metabolismus $7 D013601
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a adaptorové proteiny signální transdukční $x genetika $x metabolismus $7 D048868
650    _2
$a myši inbrední C57BL $7 D008810
655    _2
$a časopisecké články $7 D016428
700    1_
$a Grusanovic, Srdjan $u Laboratory of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Duric, Iris $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia $u Faculty of Science, Charles University, Prague, Czechia
700    1_
$a Pavliuchenko, Nataliia $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Danek, Petr $u Laboratory of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia $u Molecular Analysis of Growth Regulation in Animals, Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Borna, Simon $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Sekeresova Kralova, Jarmila $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Skopcova, Tereza $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Pokorna, Jana $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Alberich-Jorda, Meritxell $u Laboratory of Hemato-Oncology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia $u Childhood Leukaemia Investigation Prague, Department of Pediatric Haematology and Oncology, 2ndFaculty of Medicine, University Hospital Motol, Charles University, Prague, Czechia
700    1_
$a Brdicka, Tomas $u Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20241101), s. 1421512
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39555063 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104410 $b ABA008
999    __
$a ok $b bmc $g 2263353 $s 1239557
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1421512 $e 20241101 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace